Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Prestige Consumer Healthcare (PBH) Invested Capital (2016 - 2025)

Prestige Consumer Healthcare has reported Invested Capital over the past 16 years, most recently at $2.9 billion for Q4 2025.

  • For Q4 2025, Invested Capital rose 59.64% year-over-year to $2.9 billion; the TTM value through Dec 2025 reached $2.9 billion, up 59.64%, while the annual FY2025 figure was $2.8 billion, 1.67% up from the prior year.
  • Invested Capital for Q4 2025 was $2.9 billion at Prestige Consumer Healthcare, up from $1.8 billion in the prior quarter.
  • Over five years, Invested Capital peaked at $3.1 billion in Q3 2022 and troughed at $1.4 billion in Q2 2021.
  • A 5-year average of $2.3 billion and a median of $2.8 billion in 2024 define the central range for Invested Capital.
  • Biggest five-year swings in Invested Capital: surged 136.92% in 2021 and later plummeted 51.46% in 2023.
  • Year by year, Invested Capital stood at $1.5 billion in 2021, then increased by 10.9% to $1.7 billion in 2022, then decreased by 5.27% to $1.6 billion in 2023, then rose by 11.88% to $1.8 billion in 2024, then soared by 59.64% to $2.9 billion in 2025.
  • Business Quant data shows Invested Capital for PBH at $2.9 billion in Q4 2025, $1.8 billion in Q3 2025, and $1.9 billion in Q2 2025.